46 The tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) trial showed that tirzepatide 15 mg weekly led to mean reductions in body weight up to 20.9% in patients with overweight or obesity but without diabetes after 72 weeks of treatment compared with 3.1% with placebo
The Journal of Nutrition , 155 (1), 185196
Nausea, constipation, diarrhea, reflux, and reduced appetite are common
In Oakland Park, many insurance plans do include coverage for weight loss medications, such as Zepbound and Wegovy, often requiring prior authorization
Standard lager contains 180230 calories per pint with a moderate carbohydrate load, and the carbonation can worsen nausea if your GI side effects haven't fully settled